Table 4.
Stage 3 mega-analysis results.
| SNP | CHR | BP | Gene | A1/A2 | OR [95% CI] | P |
|---|---|---|---|---|---|---|
| rs61776730 | 1 | 71,057,739 | BC041441 | A/G | 1.44 [1.23–1.69] | 4.6e-06 |
| rs4370294 | 5 | 177,510,515 | N4BP3 | G/A | 1.23 [1.13–1.34] | 3.3e-06 |
| rs2603462 | 6 | 81,418,667 | BCKDHB | C/A | 1.3 [1.17–1.45] | 1.9e-06 |
| rs10738370 | 9 | 14,582,342 | ZDHHC21 | T/C | 1.25 [1.13–1.38] | 8.9e-06 |
| rs7902929 | 10 | 107,237,532 | SORCS3 | C/T | 1.51 [1.28–1.78] | 7.1e-07 |
| rs76828179 | 12 | 32,594,268 | FGD4 | A/G | 1.36 [1.19–1.56] | 5.2e-06 |
| rs61944465 | 13 | 27,272,704 | WASF3 | G/A | 1.29 [1.16–1.42] | 1.1e-06 |
| rs415468 | 19 | 44,456,672 | ZNF221 | C/G | 1.22 [1.11–1.32] | 9.3e-06 |
| rs16981092 | 20 | 19,745,011 | SLC24A3 | G/A | 1.22 [1.11–1.32] | 8.5e-06 |
Note: A1 set so that OR >= 1.
SNP: single nucleotide polymorphism; CHR: Chromosome; BP: base pair; Gene: closest protein-coding gene; A1/A2: effect/non-effect allele; OR: odds ratio; 95% CI: 95% confidence interval.